Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 45 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Women over 18 and pre-menopausal
FSDS-R above 14
Willingness to try to have sexual activity at least monthly
Willingness to use an electronic diary daily
Stable, monogamous, heterosexual relationship for at least one year
Medically acceptable method of contraception
Clinically relevant conditions which might interfere with the patient's abil ity to participate in the trial
Sexual function affected by medication
Drug dependence or abuse
Sexual partner needing treatment
Peri-Menopause or Menopause (surgical or otherwise)
Pelvic Inflammatory Disease
Major depressive Episode
Significant ECG abnormalities
Significant Neurologic findings
Significant GI, Hepatic, Cardiovascular, Renal, Hematologic, Immunologic or Respiratory findings